跳至主要内容
临床试验/NCT05572021
NCT05572021终止不适用

A Comparison of the Outcomes in Fortiva and Strattice Mesh

Wake Forest University Health Sciences2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2023年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
2
主要终点
Frequency of Participants With a Hernia Recurrence

研究概览

简要总结

A comparison of ventral hernia repair with Strattice and Fortiva mesh.Primary The study team aims to determine the hernia recurrence rates for RTI Surgical biologic mesh (Fortiva) compared to Strattice. Also the study team aims to determine the mesh related complications for RTI Surgical biologic mesh (Fortiva) compared to Strattice

详细描述

This study will be a prospective, matched study of patients using Fortiva biologic mesh to determine the rates of hernia recurrence and mesh related complication compared to Strattice mesh. Patients who meet the inclusion and exclusion criteria will be prospectively enrolled to receive a Ventral Hernia Repair (VHR) using Fortiva biologic mesh and will be compared to a retrospective cohort of patients with a VHR that utilized Strattice mesh. Patients will be propensity matched in a 1:3 (Fortiva : Strattice) fashion based on age, sex, and hernia defect size.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ventral Hernia requiring surgical repair

排除标准

  • Pregnant women

结局指标

主要结局

Frequency of Participants With a Hernia Recurrence

时间窗: 1 year follow up post surgical repair

Frequency of participants with a hernia recurrence

Percentage of Participants With a Hernia Recurrence

时间窗: 1 year follow up post surgical repair

Percentage of participants with a hernia recurrence

次要结局

  • Number of Participants With a Mesh Related Complication(1 year follow up post surgical repair)
  • Percent of Participants With a Mesh Related Complication(1 year follow up post surgical repair)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Comparison of the Outcomes in Fortiva and... | 临床试验